BMP Signaling Is a Prognostic Marker in Patients With Colorectal Cancer and Associates With Frailty

Overview

Journal Cancer Diagn Progn

Specialty Oncology

Date 2024 Jul 4

PMID 38962548

Authors

Shohei Sawata

Shota Shimizu

Yoshiaki Matsumi

Yusuke Kono

Kyoichi Kihara

Manabu Yamamoto

Teruhisa Sakamoto

Yoshihisa Umekita

Yoshiyuki Fujiwara

Affiliations

Soon will be listed here.

Abstract

Background/aim: Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-β superfamily of ligands and have been shown to promote or suppress colorectal cancer (CRC) growth. Developing treatments that target BMPs is challenging due to their multiple roles, including involvement in the inflammatory response and nutritional status. The present study evaluated the prognostic value of BMP-4, which is believed to be highly expressed in CRC, and its correlation with inflammatory and nutrition statuses in patients with CRC.

Materials And Methods: We analyzed BMP-4 expression in tumor tissues from 144 patients who underwent CRC surgery using immunohistochemistry and evaluated the relationship between BMP-4 levels and clinical outcomes.

Results: Kaplan-Meier analysis revealed that patients with high expression levels of BMP-4 exhibited a shorter overall survival rate than those with low levels of expression. Multivariate analysis revealed that BMP-4 expression was an independent prognostic factor for overall survival and death from other diseases in CRC patients. Furthermore, high BMP-4 expression was significantly correlated with high C-reactive protein/Albumin ratio, sarcopenia, and osteopenia.

Conclusion: BMP-4 is a significant prognostic factor in CRC, particularly in predicting death from other diseases, while also showing associations with inflammatory and nutritional statuses.

References

Jones D, Nakashima T, Sanchez O, Kozieradzki I, Komarova S, Sarosi I . Regulation of cancer cell migration and bone metastasis by RANKL. Nature. 2006; 440(7084):692-6. DOI: 10.1038/nature04524. View

Sharma P, Parikh N, Yu J, Barman P, Derstine B, Sonnenday C . Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients. Liver Transpl. 2016; 22(8):1092-8. PMC: 4961525. DOI: 10.1002/lt.24458. View

Fairclough E, Cairns E, Hamilton J, Kelly C . Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome. Clin Med (Lond). 2009; 9(1):30-3. PMC: 5922628. DOI: 10.7861/clinmedicine.9-1-30. View

Ehata S, Miyazono K . Bone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years. Front Cell Dev Biol. 2022; 10:883523. PMC: 9174896. DOI: 10.3389/fcell.2022.883523. View

Tae B, Cho S, Kim H, Kim C, Kang S, Lee J . Decreased expression of bone morphogenetic protein-2 is correlated with biochemical recurrence in prostate cancer: Immunohistochemical analysis. Sci Rep. 2018; 8(1):10748. PMC: 6048060. DOI: 10.1038/s41598-018-28566-9. View

Mano Y, Yoshio S, Shoji H, Tomonari S, Aoki Y, Aoyanagi N . Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma. J Gastroenterol. 2019; 54(11):1007-1018. DOI: 10.1007/s00535-019-01579-5. View

Miyazono K, Kamiya Y, Morikawa M . Bone morphogenetic protein receptors and signal transduction. J Biochem. 2009; 147(1):35-51. DOI: 10.1093/jb/mvp148. View

Fan Y, Guo L, Zheng H, Ji C, Wang W, Sun H . BMP-9 is a novel marker for colorectal tumorigenesis undergoing the normal mucosa-adenoma-adenocarcinoma sequence and is associated with colorectal cancer prognosis. Oncol Lett. 2020; 19(1):271-282. PMC: 6923933. DOI: 10.3892/ol.2019.11125. View

Tranquilli Leali P, Doria C, Zachos A, Ruggiu A, Milia F, Barca F . Bone fragility: current reviews and clinical features. Clin Cases Miner Bone Metab. 2012; 6(2):109-13. PMC: 2781230. View

10.

Winbanks C, Chen J, Qian H, Liu Y, Bernardo B, Beyer C . The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass. J Cell Biol. 2013; 203(2):345-57. PMC: 3812980. DOI: 10.1083/jcb.201211134. View

11.

Shimizu S, Matsunaga T, Sawata S, Sakano Y, Makinoya M, Shishido Y . Preoperative Osteopenia Is a Risk Factor for Death in Patients Undergoing Gastrectomy for Gastric Cancer. Anticancer Res. 2023; 43(8):3665-3672. DOI: 10.21873/anticanres.16548. View

12.

Roodman G, Dougall W . RANK ligand as a therapeutic target for bone metastases and multiple myeloma. Cancer Treat Rev. 2007; 34(1):92-101. DOI: 10.1016/j.ctrv.2007.09.002. View

13.

Sartori R, Hagg A, Zampieri S, Armani A, Winbanks C, Viana L . Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia. Sci Transl Med. 2021; 13(605). DOI: 10.1126/scitranslmed.aay9592. View

14.

Iwai-Saito K, Shobugawa Y, Aida J, Kondo K . Frailty is associated with susceptibility and severity of pneumonia in older adults (A JAGES multilevel cross-sectional study). Sci Rep. 2021; 11(1):7966. PMC: 8041848. DOI: 10.1038/s41598-021-86854-3. View

15.

Lombardo Y, Scopelliti A, Cammareri P, Todaro M, Iovino F, Ricci-Vitiani L . Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology. 2010; 140(1):297-309. DOI: 10.1053/j.gastro.2010.10.005. View

16.

Liu Y, Chen J, Yang Y, Zhang L, Jiang W . Μolecular impact of bone morphogenetic protein 7, on lung cancer cells and its clinical significance. Int J Mol Med. 2012; 29(6):1016-24. DOI: 10.3892/ijmm.2012.948. View

17.

Uchmanowicz I, Mlynarska A, Lisiak M, Kaluzna-Oleksy M, Wleklik M, Chudiak A . Heart Failure and Problems with Frailty Syndrome: Why it is Time to Care About Frailty Syndrome in Heart Failure. Card Fail Rev. 2019; 5(1):37-43. PMC: 6396065. DOI: 10.15420/cfr.2018.37.1. View

18.

Jafri S, Previgliano C, Khandelwal K, Shi R . Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients. Clin Med Insights Oncol. 2015; 9:87-93. PMC: 4640427. DOI: 10.4137/CMO.S30891. View

19.

Bouillanne O, Morineau G, Dupont C, Coulombel I, Vincent J, Nicolis I . Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005; 82(4):777-83. DOI: 10.1093/ajcn/82.4.777. View

20.

Shimizu S, Kondo J, Onuma K, Coppo R, Ota K, Kamada M . Inhibition of the bone morphogenetic protein pathway suppresses tumor growth through downregulation of epidermal growth factor receptor in MEK/ERK-dependent colorectal cancer. Cancer Sci. 2023; 114(9):3636-3648. PMC: 10475764. DOI: 10.1111/cas.15882. View